| Primary |
| Hiv Infection |
73.2% |
| Hypertension |
4.7% |
| Product Used For Unknown Indication |
3.7% |
| Factor Viii Deficiency |
2.6% |
| Acquired Immunodeficiency Syndrome |
1.6% |
| Plasmablastic Lymphoma |
1.6% |
| Prophylaxis |
1.3% |
| Asymptomatic Hiv Infection |
1.0% |
| Disseminated Cryptococcosis |
1.0% |
| Hiv Test Positive |
1.0% |
| Insomnia |
1.0% |
| Pruritus |
1.0% |
| Abdominal Pain Upper |
0.8% |
| Antifungal Prophylaxis |
0.8% |
| Atypical Mycobacterial Infection |
0.8% |
| Dyslipidaemia |
0.8% |
| Hyperlipidaemia |
0.8% |
| Pain |
0.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.8% |
| Anaemia |
0.5% |
|
| Death |
9.6% |
| Weight Increased |
9.6% |
| Blood Creatine Phosphokinase Increased |
7.7% |
| Malaise |
5.8% |
| Phlebitis |
5.8% |
| Viral Load Increased |
5.8% |
| Vomiting |
5.8% |
| Abortion Spontaneous |
3.8% |
| Asthenia |
3.8% |
| Bone Marrow Disorder |
3.8% |
| Hepatic Enzyme Increased |
3.8% |
| Intracranial Pressure Increased |
3.8% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
3.8% |
| Myocardial Infarction |
3.8% |
| Rash |
3.8% |
| Rectal Cancer |
3.8% |
| Renal Failure Acute |
3.8% |
| Renal Impairment |
3.8% |
| Respiratory Disorder |
3.8% |
| Treatment Failure |
3.8% |
|
| Secondary |
| Hiv Infection |
58.7% |
| Product Used For Unknown Indication |
6.9% |
| Prophylaxis |
6.0% |
| Acquired Immunodeficiency Syndrome |
5.7% |
| Antiretroviral Therapy |
4.0% |
| Acute Lymphocytic Leukaemia |
2.9% |
| Colitis Ulcerative |
2.3% |
| Transplant |
1.7% |
| Anti-infective Therapy |
1.4% |
| Depression |
1.4% |
| Opportunistic Infection Prophylaxis |
1.4% |
| Aphthous Stomatitis |
1.1% |
| Pneumocystis Jirovecii Pneumonia |
1.1% |
| Toxoplasmosis |
1.1% |
| Bronchopulmonary Aspergillosis |
0.9% |
| Sepsis |
0.9% |
| Cardiovascular Disorder |
0.6% |
| Chronic Hepatitis C |
0.6% |
| Colitis |
0.6% |
| Cytomegalovirus Chorioretinitis |
0.6% |
|
| Rash Generalised |
10.7% |
| Toxic Skin Eruption |
10.7% |
| Rash Maculo-papular |
8.9% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
7.1% |
| Oesophageal Candidiasis |
5.4% |
| Pyrexia |
5.4% |
| Renal Failure Acute |
5.4% |
| Cerebral Haemorrhage |
3.6% |
| Depression |
3.6% |
| Dyspnoea |
3.6% |
| Nervous System Disorder |
3.6% |
| Off Label Use |
3.6% |
| Pain In Extremity |
3.6% |
| Rash |
3.6% |
| Renal Tubular Necrosis |
3.6% |
| Rhabdomyolysis |
3.6% |
| Somnambulism |
3.6% |
| Throat Irritation |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Vitamin B12 Deficiency |
3.6% |
|
| Concomitant |
| Hiv Infection |
62.4% |
| Product Used For Unknown Indication |
7.4% |
| Chronic Hepatitis C |
6.0% |
| Non-hodgkin's Lymphoma |
5.4% |
| Hepatitis B |
4.7% |
| Antiretroviral Therapy |
2.7% |
| Lipodystrophy Acquired |
2.7% |
| Hiv Infection Cdc Category C3 |
2.0% |
| Antifungal Prophylaxis |
1.3% |
| Ear Pain |
1.3% |
| Headache |
1.3% |
| Herpes Virus Infection |
1.3% |
| Osteoporosis |
0.7% |
| Sleep Disorder Therapy |
0.7% |
|
| Skin Exfoliation |
9.7% |
| Swelling Face |
9.7% |
| Herpes Zoster |
6.5% |
| Neuropathy Peripheral |
6.5% |
| Renal Failure |
6.5% |
| Stomatitis |
6.5% |
| Varices Oesophageal |
6.5% |
| Vomiting |
6.5% |
| Weight Increased |
6.5% |
| Castleman's Disease |
3.2% |
| Cerebrovascular Accident |
3.2% |
| Interstitial Lung Disease |
3.2% |
| Lung Cancer Metastatic |
3.2% |
| Major Depression |
3.2% |
| Memory Impairment |
3.2% |
| Nephrolithiasis |
3.2% |
| Pain |
3.2% |
| Pancreatitis |
3.2% |
| Potentiating Drug Interaction |
3.2% |
| Premature Delivery |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
|
